VRTX Award Disclosure
Brennan Daniel J. · SEC Form 4 · Filed Oct 22, 2026
Award
Calculated transaction value
$400.26K
Brennan Daniel J. Director
VRTX
Transaction date
Oct 20, 2026
Public filing date
Oct 22, 2026
Filing lag
Filed 2 days later
VRTX daily price context
Close on/before transaction
$514.65
Oct 20, 2026
First close after public filing
$523.93
Oct 23, 2026
Return after filing · so far
+5.14%
Through Nov 9, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 795 shares @ $503.47
- SEC ownership
- Direct
- Transaction code
- A
- Form
- 4
- Filing identifier
- 0000875320-26-000283
Filing cohort
Transactions in this filing
Showing 1 of 1
Trades
1
Issuers
1
Estimated value
$400.26K
Buys / sales
0 / 0
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Vertex Pharmaceuticals Inc / Ma VRTX Current | Award | Oct 20, 2026 | $400.26K |